Citation

Cherney RJ, Anjanappa P, Selvakumar K, Batt DG, Brown GD, Rose AV, Vuppugalla R, Chen J, Pang J, Xu S, Yarde M, Tebben AJ, Paidi VR, Cvijic ME, Mathur A, Barrish JC, Mandlekar S, Zhao Q, Carter PH.: BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate. ACS Med Chem Lett, Volume 12 (11), 2021

Authors

Anjanappa P, Barrish JC, Batt DG, Brown GD, Carter PH., Chen J, Cherney RJ, Cvijic ME, Mandlekar S, Mathur A, Paidi VR, Pang J, Rose AV, Selvakumar K, Tebben AJ, Vuppugalla R, Xu S, Yarde M, Zhao Q

Journal

ACS Med Chem Lett

Year

2021

DOI

10.1021/acsmedchemlett.1c00373

PubMed

34795864

Machine-readable

REST APIRDF